| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |